PRKAB1 and hepatocellular carcinoma: Furthermore, in hepatocellular carcinoma cells, AMPK has been shown to exert an inhibitory effect on the p53 deacetylase Sirt1, thereby enhancing p53 acetylation and activation (Lee et al., 2012a).